IHM
EW icon

Iguana Healthcare Management’s Edwards Lifesciences EW Stock Holding History

Iguana Healthcare Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-60,000
Closed -$649K – 84
2013
Q4 		$649K Buy
+60,000
New +$676K 0.37% 62

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Iguana Healthcare Management's EW Position: Q3 2017 in Review

Iguana Healthcare Management sold out of Edwards Lifesciences (EW) in Q3 2017, closing a stake of 22,500 shares — an estimated $887K sold.

Iguana Healthcare Management first reported a position in EW in Q4 2013 and held it in 4 quarters. The position peaked at $8.53M in Q3 2015. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

  • Iguana Healthcare Management reported no remaining Edwards Lifesciences position as of Q3 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 22,500 Edwards Lifesciences shares in Q3 2017, an estimated $887K.
  • Iguana Healthcare Management first reported a position in Edwards Lifesciences in Q4 2013 and held it in 4 quarters.
  • Iguana Healthcare Management's Edwards Lifesciences position peaked at $8.53M in Q3 2015.
  • 740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Iguana Healthcare Management's 13F filing for Q3 2017, filed 14 Nov 2017.